
### [MONDO:0018157](http://purl.obolibrary.org/obo/MONDO_0018157)
**Label:** mitochondrial disorder due to a defect in mitochondrial protein synthesis

**Subclasses:** [MONDO:0010892](http://purl.obolibrary.org/obo/MONDO_0010892) (mitochondrial myopathy and sideroblastic anemia), [MONDO:0017312](http://purl.obolibrary.org/obo/MONDO_0017312) (Perrault syndrome), 

**Corr. equiv. classes:** [OMIM:600462](http://purl.obolibrary.org/obo/OMIM_600462), [Orphanet:2855](http://www.orpha.net/ORDO/Orphanet_2855), [Orphanet:2598](http://www.orpha.net/ORDO/Orphanet_2598), 

**Class expressions from DL-Learner:**

- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0040195](http://purl.obolibrary.org/obo/HP_0040195) (Decreased head circumference) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0040133](http://purl.obolibrary.org/obo/HP_0040133) (Abnormal serum ferritin) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0030791](http://purl.obolibrary.org/obo/HP_0030791) (Abnormal jaw morphology) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 66.67%
- [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 66.67%
- [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) 66.67%
- [HP:0011821](http://purl.obolibrary.org/obo/HP_0011821) (Abnormality of facial skeleton) and [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) 66.67%
- [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) 66.67%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) 66.67%
- [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0012132](http://purl.obolibrary.org/obo/HP_0012132) (Erythroid hyperplasia) 66.67%


